Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02416921 · ClinicalTrials.gov registry record · NA

Preventing Weight Gain in African American Reproductive-Aged Women

A NA study of Obesity and Weight Gain, sponsored by Washington University School of Medicine.

Completed
Registry status
NA
Development phase
18
Enrollment target
1
Study location

NCT02416921: Completed NA study of Obesity and Weight Gain, sponsored by Washington University School of Medicine.

NCT02416921 is a NA study of Obesity and Weight Gain that has completed, run by Washington University School of Medicine. The registered enrollment target is 18 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02416921, a NA study of Obesity and Weight Gain, has completed, sponsored by Washington University School of Medicine.

COMPLETED
Registry status
NA
Development phase
18 participants
Enrollment target
1
Study location

Study Summary

The purpose of this research study is to evaluate the effect of a Facebook-delivered weight-gain prevention program versus a Facebook-delivered program with general women's health information.

Interventions

  • BEHAVIORAL Weight-gain Prevention
  • BEHAVIORAL Women's Health

Study Locations (1)

Missouri

  • Washington University School of Medicine - St Louis

Trial Details

FieldValue
Enrollment Target 18 participants
Start Date 2015-04
Est. Completion 2015-09
Phase NA

What the finished NCT02416921 record still lists

NCT02416921 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 18 participants, a relatively small participant target, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (98% lower).

The record links to 3 conditions, with Obesity appearing as the primary indexed condition, and to 2 interventions - of which Weight-gain Prevention is the first listed.

NCT02416921 reports a single indexed study location in Missouri.

Frequently Asked Questions

What is clinical trial NCT02416921 about?

NCT02416921 is a clinical study titled "Preventing Weight Gain in African American Reproductive-Aged Women". The purpose of this research study is to evaluate the effect of a Facebook-delivered weight-gain prevention program versus a Facebook-delivered program with general women's health information.

What is the current status of trial NCT02416921?

This trial is currently completed. It is a NA study. The enrollment target is 18 participants. The study started on 2015-04. Estimated completion is 2015-09.

What conditions does trial NCT02416921 study?

This clinical trial studies the following conditions: Obesity, Weight Gain, Women's Health.

What interventions are being tested in trial NCT02416921?

The interventions under investigation include: Weight-gain Prevention (BEHAVIORAL), Women's Health (BEHAVIORAL).

Who is sponsoring clinical trial NCT02416921?

This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02416921 being conducted?

This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02416921's enrollment target sits among peer trials

18 982nd of 1053 higher than 64 of 1,053 other Obesity trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01245179 · 18 participants · Phase 1

    Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease

  • NCT01999361 · 18 participants · NA

    Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss

  • NCT02359825 · 18 participants · Phase 1

    Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function

  • NCT02870244 · 18 participants · Phase 1

    Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02416921, the US trial registry maintained by the National Library of Medicine. NCT02416921 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.